Mentice publishes the company’s interim report for the period July–September 2020
Two exciting acquisitions and strong performance in the medical device industry segment Third quarter (July–September 2020) · Net sales amounted to 33.4 (29.3) MSEK. · Operating income for the period before depreciations (EBITDA) totalled 4.1 (-6.7) MSEK. · Net income for the period amounted to -0.3 (-9.0) MSEK. · Earnings per share (EPS) was -0.01 (-0.37) SEK. · Order intake amounted to 34.6 (24.4) MSEK. · Cash flow from operating activities totalled -6.2 (-16.2) MSEK. First nine months of the year (January–September 2020) · Net sales for the first nine